Jin Kim Montclare
Professor, Tandon School of Engineering
Jin Kim Montclare is a Professor in the Department of Chemical and Biomolecular Engineering, who is performing groundbreaking research in engineering proteins to mimic nature and, in some cases, work better than nature. She works to customize artificial proteins with the aim of targeting human disorders, drug delivery and tissue regeneration as well as create nanomaterials for electronics.
Alexander Parker
Cecilia and Dan Carmichael Family Associate Director, Center for Individualized Medicine (Florida)
Alexander Parker, Ph.D., is a professor of Epidemiology and Urology at the Mayo Clinic. He is also the Cecilia and Dan Carmichael Family Associate Director of the Center for Individualized Medicine at the Mayo Clinic in Florida, which was launched in 2012 to advance research and clinical practice in the field of individualized medicine. Dr. Parkers research aims to improve our understanding of the molecular epidemiology of kidney cancer, with a particular focus on addressing clinical and public health questions. He received his Ph.D. in epidemiology from the University of Iowa and completed a post-doctoral fellowship in molecular and genetic epidemiology at the Mayo Clinic.
Jan Pietzsch
Adjunct Professor, Management Science & Engineering
Director, Health Economics & Value, Stanford Biodesign
Jan Pietzschs professional and academic work focus on early-stage technology assessment and strategic decision-support for investors, manufacturers, and research institutions. A primary emphasis is on the early evaluation of the value proposition of new technologies to provide quantitative input into the selection of the most promising technology concepts and their targeted development. This includes model-based assessment of the clinical and health-economic benefit of new diagnostics and therapies.
Deepti Pradhan
Senior Research Analyst, Office of Development
Deepti Pradhan is a Senior Research Analyst in the Yale Office of Development, and a 2015 Public Voices Fellow at The Op-Ed Project. After spending the better part of her career immersed in chemistry, biochemistry, and cell biology, including 13 years on the faculty of the Yale School of Medicine, Dr. Pradhan changed direction and moved to the Yale Office of Development in 2008, where she uses her skills in data analysis to enhance donor support for the university. She sustains her passion for science through Tilde Café, an independent not-for-profit science café she founded in 2008.
Vinay Prasad
Vinay K. Prasad, M.D., M.P.H. is a hematologist-oncologist and Assistant Professor of Medicine at the Oregon Health and Sciences University. He also holds appointments in the Division of Public Health and Preventive Medicine, and as a Senior Scholar in the Center for Health Care Ethics. He is nationally known for his research on oncology drugs, health policy, evidence-based medicine, bias, public health, preventive medicine, and medical reversal. He is a graduate of The University of Chicago Pritzker School of Medicine and completed his residency in internal medicine at Northwestern Universitys Feinberg School of Medicine.
Heidi Rehm
Associate Professor of Pathology, Harvard Medical School
Heidi Rehm, Ph.D., FACMG is the Chief Laboratory Director of the Laboratory for Molecular Medicine (LMM) at the Partners Healthcare Center for Personalized Genetic Medicine (PCPGM). She is a board-certified clinical molecular geneticist and Associate Professor of Pathology at Harvard Medical School with appointments at Brigham and Womens Hospital, Massachusetts General Hospital, and Children’s Hospital Boston. Dr. Rehm has served as the Director of the American Board of Medical Genetics Clinical Molecular Genetics Training Program at Harvard Medical School since 2006. In addition to running the LMM and the molecular training program, she also conducts research on hearing loss, Usher syndrome, cardiomyopathy, and the use of IT in enabling personalized medicine.
Erin Riggs
Genetic Counselor, Autism and Developmental Medicine Institute
Erin Rooney Riggs, MS, CGC is a certified genetic counselor at Geisinger Health Systems Autism and Developmental Medicine Institute and the co-coordinator of the International Collaboration for Clinical Genomics (ICCG). Previously, she served as a clinical genetic counselor at Emory University School of Medicine, focusing on general pediatrics and lysosomal storage disorders. Her research interests include the identification and characterization of the genetic causes of neurodevelopmental disorders, the effects of gene dosage, and the clinical utility of genomic testing.
Ravi Sarpatwari
M.D. Candidate, Warren Alpert Medical School
Ravi Sarpatwari is an M.D. candidate at the Warren Alpert Medical School of Brown University. Ravi is a co-founder of Design+Health, a collaboration between the Alpert Medical School and the Rhode Island School of Design that serves as an incubator for innovative design solutions to improve individual and community health.
Stephen Sheinkopf
Associate Professor of Psychiatry & Human Behavior and of Pediatrics, Warren Alpert Medical School
Stephen J. Sheinkopf is an assistant professor of psychiatry and pediatrics at The Warren Alpert Medical School at Brown University. He works as both a clinician and a researcher with expertise is the area of autism and developmental disabilities. Dr. Sheinkopf is also co-director of the Rhode Island Consortium for Autism Research and Treatment and co-leader of the autism research initiative in the Hassenfeld Child Health Innovation Institute at the Brown School of Public Health.
Bill Wuest
Georgia Research Alliance Distinguished Investigator and Associate Professor, Chemistry
In July of 2011, Bill began his career as an Assistant Professor at Temple University and in 2016 was named the Daniel Swern Early Career Professor of Chemistry. In 2017, he then moved to Emory University where he is currently a Georgia Research Alliance Distinguished Investigator and Associate Professor of Chemistry. His research focuses on the modification of natural products through total synthesis in an effort to develop innovative, pathogen-specific therapeutics.
Paul Yock
Founder & Director, Byers Center for Biodesign
Paul Yock is a cardiologist, health technology innovator, and professor of medicine and bioengineering at Stanford University. He is the Founder and Director of Stanfords Byers Center for Biodesign, a pioneering innovation training program dedicated to the design and development of medical technologies. He is also the Martha Meier Weiland Professor of Medicine and Mechanical Engineering and Founding Co-Chair of Stanford’s Department of Bioengineering.
Paul is internationally known for his work in inventing, developing, and testing new devices and has co-founded several medical technology companies. In his academic career, he has authored over 300 peer-reviewed publications, chapters and editorials, textbooks, and over 45 U.S. patents. Paul received his M.D. from Harvard Medical School.